Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) announced today that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and…
Category: Insights
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Immunic, Inc. (Nasdaq: IMUX),a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating…
PHBI – Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard
Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a second management update form CEO Peter Wojcik. Today’s…
Aesthetic Lasers and Energy Devices Market to grow by USD 861.45mn|Evolving Opportunities with AbbVie Inc. & Bausch Health Companies Inc.| 17000+ Technavio Reports
The aesthetic lasers and energy devices market report offers information on several market vendors, including AbbVie Inc.,…
Global Patient Engagement Solutions Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts
The “Patient Engagement Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been…
Jelly Jim Positioned as One of the Leading Nutraceutical Brands with a Premium Collection of Products
Jelly Jim, a leader in the nutraceutical space, is prepared to welcome a new Q4 full…
Ingenovis Health to Acquire HealthCare Support
– Ingenovis Health, Inc. (“Ingenovis” or the “Company”), a leading tech-enabled platform for healthcare staffing backed…
High-Pressure Contrast Media Injectors Market to grow by USD 113.21 by 2026
The “High-Pressure Contrast Media Injectors Market – Competitive Analysis, Challenges, Drivers & Five Force Analysis” report has…
World Stroke Day: Global survey reveals only 35% hospitals worldwide provide essential stroke treatment
On World Stroke Day, 29 October, the World Stroke Organization (WSO) is calling for urgent action…
Arbor Rapha Capital Bioholdings Corp. I Announces Pricing of $150 Million Initial Public Offering
Arbor Rapha Capital Bioholdings Corp. I (the “Company”) announced today that it priced its initial public offering…